Effectiveness of Recombinant Human Growth Hormone for Pharyngocutaneous Fistula Closure [PDF]
ObjectivesIn laryngeal cancer, which comprises 25% of head and neck cancer, chemotherapy has come into prominence with the increase in organ-protective treatments.
Nurten Kucuk +5 more
doaj +3 more sources
Ten years of biosimilar recombinant human growth hormone in Europe [PDF]
Paul Saenger Division of Pediatric Endocrinology, Department of Pediatrics, Winthrop University Hospital, Mineola, NY, USA Abstract: Recombinant human growth hormone (rhGH) has been in clinical use for more than 30 years.
Saenger P
doaj +2 more sources
Recombinant human growth hormone treatment of Floating-Harbor syndrome: a case report and literature review [PDF]
Background Floating Harbor syndrome (FHS) is a rare genetic disorder with over 100 reported cases worldwide and less than 30 treated with recombinant human growth hormone (rhGH).
Qing He +5 more
doaj +2 more sources
Self-administration of Recombinant Human Growth Hormone with an Electronic Device: Clinical, Economic and Management Benefits of Objective Adherence Monitoring [PDF]
# Purpose The aim was to identify factors affecting treatment adherence and to assess the clinical, economic and management impact of growth hormone deficiency treatment using an electronic auto-injector for recombinant human growth hormone (r-hGH ...
Zuleika Saz-Parkinson +4 more
doaj +1 more source
Optimization of production of recombinant human growth hormone in Escherichia coli
Background: Human growth hormone (hGH) is a single-chain polypeptide that participates in a wide range of biological functions such as metabolism of proteins, carbohydrates and lipids as well as in growth, development and immunity.
Marzieh Rezaei +1 more
doaj +1 more source
Ten years' clinical experience with biosimilar human growth hormone: a review of efficacy data
Juan Pedro López-Siguero,1 Roland Pfäffle,2 Philippe Chanson,3 Mieczyslaw Szalecki,4,5 Nadja Höbel,6 Markus Zabransky6 1Servicio de Endocrinología Pediátrica, Hospital Materno-Infantil, Hospital Regional Universitario de M&
López-Siguero JP +5 more
doaj +1 more source
Ten years of clinical experience with biosimilar human growth hormone: a review of safety data
Maria Victoria Borrás Pérez,1 Berit Kriström,2 Tomasz Romer,3 Mieczyslaw Walczak,4 Nadja Höbel,5 Markus Zabransky5 1Hospital General de Granollers, Granollers, Barcelona, Spain; 2Department of Clinical Sciences, Pediatrics, Ume ...
Borrás Pérez MV +5 more
doaj +1 more source
Adherence to recombinant human growth hormone therapy in children: influencing factors and clinical implications. [PDF]
Chang W, Jin H, Zhou Q, Ye K, Dai Y.
europepmc +2 more sources
Global trends in recombinant human growth hormone for the treatment of idiopathic short stature: a bibliometric analysis. [PDF]
Ouyang R, Gu H, Yuan J, Sun Y, Zhao X.
europepmc +2 more sources
Laron syndrome: An experience of treatment of two cases
Laron syndrome or growth hormone insensitivity is a rare disease presenting with severe postnatal growth failure. Clinically, in most circumstances, it is indistinguishable from growth hormone deficiency.
Hiya Boro +4 more
doaj +1 more source

